(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IPLEDGE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

IPLEDGE

ST13

US500000085925694

Class

35, 44, 45

Filing

85925694

Registration

4493966

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

07/10/2024

Trademark type

Word

Nice classes

35, 44, 45

Filing date

05/07/2013

Registration date

03/11/2014

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/10/2024

Last transaction

07/10/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

08/22/2005

First use in commerce

08/22/2005

Drawing code

4

Owner type

16

Owner location

BLUE BELL, PA

Examiner

LEIPZIG, MARC J

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

UNITED BIOSOURCE LLC
McKesson Speciality Arizona, Inc.

Representatives

Lisa Casey Spaniel Blank Rome LLP

Technical classification

Nice Classes

Class 35Class 44Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Maintaining a medical registry of certified medical technical professionals in the area of prescription medicines; interactive record keeping services for use in risk management and regulatory compliance to ensure the proper prescribing and dispensing of pharmaceuticalsfor use by physicianspharmacistspatients

Class 44

Providing medical information for physicianspharmacistspatients in the field of prescription medicine

Class 45

Regulatory compliance consulting in the field of prescription drug medicine

Publications

History of USPTO decisions and trademark events.

31 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/10/2024

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

07/10/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/10/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/10/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

04/11/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

03/11/2023

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/26/2022

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

04/29/2020

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

04/29/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/29/2020

E815

TEAS SECTION 8 & 15 RECEIVED

03/05/2020

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

03/11/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/12/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/13/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

03/11/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/24/2013

PUBO

PUBLISHED FOR OPPOSITION

12/24/2013

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/04/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/19/2013

ALIE

ASSIGNED TO LIE

11/18/2013

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/29/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/29/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/28/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/28/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/31/2013

GNRT

NON-FINAL ACTION E-MAILED

08/31/2013

CNRT

NON-FINAL ACTION WRITTEN

08/31/2013

DOCK

ASSIGNED TO EXAMINER

08/24/2013

MPMK

NOTICE OF PSEUDO MARK E-MAILED

05/15/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/14/2013

NWAP

NEW APPLICATION ENTERED

05/10/2013

Continuous trademark protection

Get notified about every new filing that threatens IPLEDGE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.